<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Infliximab, a chimeric monoclonal anti-TNF-alfa agent used to treat <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>, has shown a paradoxical side effect in the development of <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We describe a case of <z:hpo ids='HP_0002229'>alopecia areata</z:hpo> universalis associated with infliximab treatment in a patient with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease </plain></SENT>
<SENT sid="2" pm="."><plain>This case suggests a complex and contradictory role of TNF-α in the pathogenesis of <z:hpo ids='HP_0002229'>alopecia areata</z:hpo> </plain></SENT>
</text></document>